Streetbeat News

Products Services

GCAD

HON

PPA

Honeywell International Inc. (NASDAQ: HON) reported strong Q2 earnings driven by aerospace growth but lowered its FY24 EPS outlook. Revenue grew 5% Y/Y to $9.58 billion, beating expectations. Adjusted EPS was $2.49, also beating estimates. Despite positive growth in three of its four segments, the company lowered its FY24 EPS guidance and segment margin outlook. Honeywell shares are down 4.52% premarket. Investors can gain exposure via Gabelli Commercial Aerospace And Defense ETF (NYSE: GCAD) and Invesco Aerospace & Defense ETF (NYSE: PPA).

Portfolio Pulse from Lekha Gupta

July 25, 2024 | 1:07 pm

DASH

Save A Lot has partnered with DoorDash to offer same-day grocery delivery from over 400 stores, with plans to support SNAP/EBT payments later this year.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:07 pm

DSP

Viant Technology Inc. (NASDAQ:DSP) and Havas Media Network successfully executed a cookieless advertising test, achieving 100% scale and 93% unique reach using Viant's Household ID™. The test was conducted for a major US-based pharmaceutical advertiser.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:06 pm

MRVL

Marvell's Teralynx 10 switch is now available in the Linux Foundation's open-source SONiC, enabling the deployment of 51.2 Tbps Ethernet switches in open network platforms.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:05 pm

TTEK

Tetra Tech, Inc. (NASDAQ:TTEK) has been selected by the U.S. Department of Defense Environmental Security Technology Certification Program to design and test a mobile treatment technology for PFAS-impacted soils and sediments.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:05 pm

SUGP

SU Group Holdings Limited (NASDAQ:SUGP) has been awarded a significant new order at Hong Kong International Airport, which is expected to positively impact its sales growth. Financial terms were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:04 pm

SXTP

60 Degrees Pharmaceuticals has been awarded a contract with the U.S. Army to validate new packaging for ARAKODA. The company reported a 515% year-over-year increase in Q1 2024 ARAKODA sales revenue, reaching $105.7K, and has increased its commercial batch size in anticipation of higher sales volume.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:04 pm

LIQT

LiqTech International, Inc. (NASDAQ:LIQT) has entered into a partnership with Danbee Marine Co. Ltd. to market its marine scrubber water treatment solutions in South Korea, the second largest shipbuilding market globally.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:02 pm

EW

MXL

POAI

Market-Moving News for July 25th: Edwards Lifesciences (EW) shares drop 24% after poor Q2 sales and weak Q3 guidance, despite acquiring JenaValve and Endotronix. MaxLinear (MXL) shares fall 27% following disappointing Q2 results. Predictive Oncology (POAI) shares surge 117% after entering the biomarker discovery market with successful ovarian cancer study results.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:01 pm

GLYC

GlycoMimetics (GLYC) will conduct an additional clinical trial for Uproleselan in relapsed/refractory acute myeloid leukemia (AML) following an FDA meeting. The company is initiating a strategic review and corporate restructuring, reducing its workforce by 80%. GlycoMimetics has engaged Lucid Capital Markets as a strategic advisor and is advancing a Phase 2/3 study of Uproleselan in newly diagnosed AML patients with the NCI and Alliance for Clinical Trials. The company's cash is expected to fund operations into Q2 2025.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:01 pm